Podcast

Breaking the Ice: Talking to Your Patients About Naloxone

Launch Date
06/08/2020
Credit Amount
0.00 Expired
Credit Expires
06/08/2021
This activity is part of a series

Faculty

Neil Skolnik, MD
Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University
Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Jenkintown, PA
Neil Skolnik, MD

Dr. Neil Skolnik, MD, is an academic family physician who sees patients and teaches residents and medical students in the family medicine residency program at Abington Jefferson Health in Abington, Pennsylvania. He is a Professor of Family and Community Medicine at the Sidney Kimmel Medical College of Thomas Jefferson University and Associate Director of the Family Medicine Residency Program at Abington Jefferson Health. Dr. Skolnik graduated from Emory University School of Medicine in Atlanta, Georgia, and completed his residency training at Thomas Jefferson University Hospital in Philadelphia. Dr. Skolnik has written and edited 5 books: On the Ledge: A Doctor’s Stories From the Inner City; Essential Practice Guidelines for Primary Care; Essential Infectious Disease Topics for Primary Care; Sexually Transmitted Diseases for Primary Care; and Electronic Medical Records: A Practical Guide for Primary Care. He served as series editor for fifteen years, overseeing the development of over twenty-five titles in the Humana Press Current Clinical Practice in Primary Care series of medical textbooks, and has published more than 300 articles, columns, poems, and essays in both the medical and lay literature on a diverse range of subjects including laboratory diagnosis, disease management, guideline-based medical care, handheld technology in medicine, electronic health records, and medical humanities. He serves on the Expert Panel Report 4 (EPR-4) Working Group, National Asthma Education and Prevention Program Coordinating Committee, National Heart Lung Blood Institute (NHLBI), and is on the Primary Care Advisory Committee for the American Diabetes Association. Dr. Skolnik lectures nationally on a range of topics, with a special interest in diabetes, asthma, COPD, exercise in medicine, and coronary disease risk factor management. He produces “Diabetes Core Update,” the American Diabetes Association’s monthly podcast, reviewing the most important new articles to come out in core journals for practicing clinicians, and hosts the Infectious Diseases Society of America’s Guideline Podcast series.

Explore By Section
Statement of Need Learning Objectives Financial Support Target Audience Credit Information Disclosure Declaration Obtaining Credit

Statement of Need

Due to the considerable number of risk factors for overdose in patients with OUD or those on high dose opioids for chronic pain, it is imperative that health care professionals (HCPs) are familiar with the use of naloxone and its availability. Naloxone products for home use by patients or caregivers can reduce the risk of overdose deaths in both patients and household contacts; therefore, it is imperative that HCPs educate patients who are at risk for overdose on its role and means of administration.

The final episode of this CMEOCast podcast series highlights the multitude of risk factors for opioid overdose that clinicians treating patients with chronic pain need to be aware of, as well as strategies for counseling patients about naloxone.

Learning Objectives

At the end of this CME/CE activity, participants should be able to:

  • Recognize risk factors for overdose in patients with OUD or those on high dose opioids for chronic pain.
  • Develop and implement strategies for educating patients who are at risk for overdose on the role of naloxone.

The following learning objectives pertain only to those requesting CNE or CPE credit:

  • Recognize risk factors for overdose in patients with OUD or those on high dose opioids for chronic pain.
  • Describe strategies for educating patients who are at risk for overdose on the role of naloxone.

Financial Support

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see here for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA).

Target Audience

Physicians, dentists, PAs, nurse practitioners, and pharmacists.

Credit Information

Physicians (ACCME) 1.0

CME Outfitters, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

REMS

In order for this activity to count towards your REMS requirements, you must complete the posttest and evaluation. CME Outfitters is responsible for submitting your completion to the FDA for REMS requirements.

Pharmacists/Pharmacy Tech (ACPE) 1.0

This application-based activity is approved for 1.0 contact hour (0.10 CEUs) of continuing pharmacy credit.
Activity UAN: 0376-0000-20-097-H08-P

ABIM MOC 1.0

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

ABPN MOC

ABPN Diplomates may select any CME activity relevant to their practice to count towards ABPN MOC requirements.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Note to Nurse Practitioners

Nurse Practitioners can apply for AMA PRA Category 1 Credit ™ through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 Credit ™ from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Skolnik has no disclosures to report.

  • Tony Graham, MD (peer reviewer) has no disclosures to report.
  • Mae Ochoa, RPh (peer reviewer) has no disclosures to report.
  • Evan Luberger (planning committee) has no disclosures to report.
  • Jan Perez (planning committee) has no disclosures to report.
  • Sharon Tordoff (planning committee) has no disclosures to report.
  • Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Obtaining Credit

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

 

NOTE: Pharmacist CE Universal Activity Number, Enduring: 0376-0000-20-097-H08-P.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

PD-020-060220-62

Breaking the Ice: Talking to Your Patients About Naloxone
Event Date: 06/08/2020

Activities in the Series

06/08/2020

Breaking the Ice: Talking to Your Patients About Naloxone

0.00 Expired
Learn More
03/25/2020

Heeding the Call for Safe and Responsible Pain Management in Our Communities

0.00 Expired
Learn More